The Use of Vitamin K2 in Patients With Parkinson's Disease and Mitochondrial Dysfunction (PD-K2): A Theranostic Pilot Study in a Placebo-Controlled Parallel Group Design

Background: Despite rapid advances in research on Parkinson's disease (PD), in particular in the elucidation of genetic contributions, no disease-modifying therapy has become available to date. Objectives: In the proposed project, we aim to investigate the potential effects of vitamin K2 (long-...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Neurol
Asıl Yazarlar: Prasuhn, Jannik, Kasten, Meike, Vos, Melissa, König, Inke R., Schmid, Sebastian M., Wilms, Britta, Klein, Christine, Brüggemann, Norbert
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2021
Konular:
Neurology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7829299/
https://ncbi.nlm.nih.gov/pubmed/33505346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.592104
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller